{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:42:52Z","timestamp":1776462172480,"version":"3.51.2"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS091859"],"award-info":[{"award-number":["NS091859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2T32GM007526"],"award-info":[{"award-number":["2T32GM007526"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 HD083082"],"award-info":[{"award-number":["U54 HD083082"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS051630"],"award-info":[{"award-number":["NS051630"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1093\/hmg\/ddy410","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T15:10:04Z","timestamp":1542985804000},"page":"980-991","source":"Crossref","is-referenced-by-count":16,"title":["Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor\/ataxia syndrome"],"prefix":"10.1093","volume":"28","author":[{"given":"Ha Eun","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghwa","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiran","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luoxiu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanghong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily G","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"key\n\t\t\t\t2019030508060105500_ref1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/nyas.12693","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"1338","author":"Hagerman","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"key\n\t\t\t\t2019030508060105500_ref3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019030508060105500_ref4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12311-016-0776-y","article-title":"A majority of FXTAS cases present with intranuclear inclusions within Purkinje cells","volume":"15","author":"Ariza","year":"2016","journal-title":"Cerebellum"},{"key":"key\n\t\t\t\t2019030508060105500_ref5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019030508060105500_ref6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.1675488","article-title":"Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n","volume":"252","author":"Kremer","year":"1991","journal-title":"Science"},{"key":"key\n\t\t\t\t2019030508060105500_ref7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019030508060105500_ref8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0959-437X(02)00299-X","article-title":"The fragile X premutation: into the phenotypic fold","volume":"12","author":"Hagerman","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"key\n\t\t\t\t2019030508060105500_ref9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1245831","article-title":"Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome","volume":"343","author":"Colak","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t2019030508060105500_ref10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/11.4.371","article-title":"Premutation and intermediate-size FMR1 alleles in 10\u00a0572 males from the general population: loss of an AGG interruption is a late event in the generation","volume":"11","author":"Dombrowski","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref11","first-page":"1006","article-title":"Prevalence of carriers of premutation-size alleles of the FMRI gene\u2014and implications for the population genetics of the fragile X syndrome","volume":"57","author":"Rousseau","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X\u2013associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019030508060105500_ref13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019030508060105500_ref14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/hmg\/10.16.1693","article-title":"Instability of a (CGG)98 repeat in the Fmr 1 promoter","volume":"10","author":"Bontekoe","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gene.2007.02.026","article-title":"Regional FMRP deficits and large repeat expansions into the full mutation range in a new fragile X premutation mouse model","volume":"395","author":"Entezam","year":"2007","journal-title":"Gene"},{"key":"key\n\t\t\t\t2019030508060105500_ref16","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/hmg\/ddp182","article-title":"Ectopic expression of CGG containing mRNA is neurotoxic in mammals","volume":"18","author":"Hashem","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0896-6273(03)00533-6","article-title":"RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila","volume":"39","author":"Jin","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t2019030508060105500_ref18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2144\/000113133","article-title":"What is metabolomics all about?","volume":"46","author":"Roessner","year":"2009","journal-title":"Biotechniques"},{"key":"key\n\t\t\t\t2019030508060105500_ref19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11306-014-0711-5","article-title":"Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model","volume":"11","author":"Van Assche","year":"2015","journal-title":"Metabolomics"},{"key":"key\n\t\t\t\t2019030508060105500_ref20","doi-asserted-by":"crossref","first-page":"e7551","DOI":"10.1371\/journal.pone.0007551","article-title":"Metabolomic profiling in LRRK2-related Parkinson\u2019s disease","volume":"4","author":"Johansen","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019030508060105500_ref21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mds.26992","article-title":"Metabolic profiling of Parkinson\u2019s disease and mild cognitive impairment","volume":"32","author":"Burt\u00e9","year":"2017","journal-title":"Mov. Disord."},{"key":"key\n\t\t\t\t2019030508060105500_ref22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"key\n\t\t\t\t2019030508060105500_ref23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s13238-015-0185-x","article-title":"Functional metabolomics: from biomarker discovery to metabolome reprogramming","volume":"6","author":"Peng","year":"2015","journal-title":"Protein Cell"},{"key":"key\n\t\t\t\t2019030508060105500_ref24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12017-010-8121-y","article-title":"Alterations of the sphingolipid pathway in Alzheimer\u2019s disease: new biomarkers and treatment targets?","volume":"12","author":"Mielke","year":"2010","journal-title":"Neuromolecular Med."},{"key":"key\n\t\t\t\t2019030508060105500_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo7030042","article-title":"Biomarker research in Parkinson\u2019s disease using metabolite profiling","volume":"7","author":"Havelund","year":"2017","journal-title":"Metabolites"},{"key":"key\n\t\t\t\t2019030508060105500_ref26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11306-016-1084-8","article-title":"Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington\u2019s disease peripheral blood samples","volume":"12","author":"Mastrokolias","year":"2016","journal-title":"Metabolomics"},{"key":"key\n\t\t\t\t2019030508060105500_ref27","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019030508060105500_ref28","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1042\/BCJ20160585","article-title":"Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation","volume":"473","author":"Giulivi","year":"2016","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t2019030508060105500_ref29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"1841","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t2019030508060105500_ref30","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"key\n\t\t\t\t2019030508060105500_ref31","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key\n\t\t\t\t2019030508060105500_ref32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/glia.20626","article-title":"Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes","volume":"56","author":"Wang","year":"2008","journal-title":"Glia"},{"key":"key\n\t\t\t\t2019030508060105500_ref33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-009-8096-6","article-title":"Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders","volume":"41","author":"Piccinini","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"key\n\t\t\t\t2019030508060105500_ref34","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.bbamcr.2013.04.010","article-title":"The complexity of sphingolipid biosynthesis in the endoplasmic reticulum","volume":"1833","author":"Tidhar","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t2019030508060105500_ref35","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","article-title":"Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes","volume":"287","author":"Ginkel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t2019030508060105500_ref36","doi-asserted-by":"crossref","first-page":"e1002063","DOI":"10.1371\/journal.pgen.1002063","article-title":"A deficiency of ceramide biosynthesis causes cerebellar Purkinje cell neurodegeneration and lipofuscin accumulation","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"key\n\t\t\t\t2019030508060105500_ref38","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t2019030508060105500_ref39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t2019030508060105500_ref40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/365557a0","article-title":"Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens","volume":"365","author":"Olivera","year":"1993","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030508060105500_ref41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030508060105500_ref42","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.R200008200","article-title":"The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind","volume":"277","author":"Hannun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t2019030508060105500_ref43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0216127","article-title":"The therapeutic potential of modulating the ceramide\/sphingomyelin pathway","volume":"110","author":"Kolesnick","year":"2002","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t2019030508060105500_ref44","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/hmg\/ddx148","article-title":"Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor\/ataxia syndrome","volume":"26","author":"Robin","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t2019030508060105500_ref45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fncel.2017.00128","article-title":"Fragile X-associated tremor\/ataxia syndrome: from molecular pathogenesis to development of therapeutics","volume":"11","author":"Kong","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"key\n\t\t\t\t2019030508060105500_ref46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1534\/genetics.115.179457","article-title":"Drosophila as an in vivo model for human neurodegenerative disease","volume":"201","author":"McGurk","year":"2015","journal-title":"Genetics"},{"key":"key\n\t\t\t\t2019030508060105500_ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ctdb.2016.07.001","article-title":"Fly models of human diseases","volume":"121","author":"Sen","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"key\n\t\t\t\t2019030508060105500_ref48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-8-35","article-title":"Drosophila melanogaster as a model organism for Alzheimer\u2019s disease","volume":"8","author":"Pr\u00fc\u00dfing","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t2019030508060105500_ref49","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1073\/pnas.0507359103","article-title":"From the cover: drosophila as a model for the identification of genes causing adult human heart disease","volume":"103","author":"Wolf","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"key\n\t\t\t\t2019030508060105500_ref50","first-page":"132","article-title":"High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics","volume":"04","author":"Evans","year":"2014","journal-title":"Metabolomics"},{"key":"key\n\t\t\t\t2019030508060105500_ref51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1758-2946-2-9","article-title":"Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries","volume":"2","author":"DeHaven","year":"2010","journal-title":"J. Cheminform."},{"key":"key\n\t\t\t\t2019030508060105500_ref52","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019030508060105500_ref53","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/6\/980\/28011132\/ddy410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T08:10:35Z","timestamp":1551773435000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/6\/980\/5209926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,11,26]]},"published-print":{"date-parts":[[2019,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy410","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2018,11,26]]}}}